72266-0243 Bortezomib - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

72266-0243

Brand Name:

Bortezomib

Generic Name:

Bortezomib

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: BORTEZOMIB

Strength: 1.0

Unit: mg/1

Packages:

Code: 72266-0243-01

Description: 1 INJECTION in 1 VIAL, SINGLE-DOSE (72266-243-01)

Effective Date: Aug. 23, 2022

Discontinued: June 30, 2024

SEER*Rx Category:

Chemotherapy

Major Class:

Proteasome Inhibitor

Minor Class:

26S

Orphan Drug Designation:

Status:

No Longer Used